Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Naganand Sripathi"'
Autor:
Anza B. Memon, Sarah Madani, Bashiruddin K. Ahmad, Kavita Grover, Ximena Arcila-londono, Lonni Schultz, Naganand Sripathi
Publikováno v:
Clinical Neurophysiology Practice, Vol 4, Iss , Pp 190-193 (2019)
Objectives: To evaluate sensory electrophysiology, terminal latency index (TLI), and treatment response in idiopathic and diabetic chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Methods: We performed a retrospective review of 147 p
Externí odkaz:
https://doaj.org/article/97cc97e2e71e40ada6036d98740b3a16
Autor:
Kavita M. Grover, Naganand Sripathi
Publikováno v:
Seminars in neurology.
In this article, we review prevention of serious adverse clinical outcomes and treatment side effects in patients with neuromuscular disorders including myopathies and myasthenia gravis. While neither of these entities is preventable, their course ca
COVID-19 infection has been reported to be associated with neurological complications including neuromuscular symptoms/syndromes. The underlying mechanism is felt to be most likely autoimmune, though direct neuroinvasion or neurotropism of the virus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bde21633447dda96e7da73dffae9d99
https://doi.org/10.1016/b978-0-323-82691-4.00011-x
https://doi.org/10.1016/b978-0-323-82691-4.00011-x
Autor:
Alex Abou Chebl, Hassan Aboul Nour, Ashhar Ali, Owais Khadem Alsrouji, Gregory L. Barkley, Helena Bulka, Mirela Cerghet, Jules E.C. Constantinou, Omar A. Danoun, Elissa Fory, Shailendra Giri, Kavita M. Grover, Angelos Katramados, Hannah Kopinsky, Shelley Lee, Peter A. LeWitt, Tessa M. LeWitt, Chandan Mehta, Anza B. Memon, Panayiotis D. Mitsias, Ghada A. Mohamed, Ali Mohamud, Daniel Newman, Gamaleldin Osman, Jacob Pawloski, Ahmad Riad Ramadan, Mohammed F. Rehman, James M. Snyder, Naganand Sripathi, Natalie Stec, Aarushi Suneja, Ritika Suri, Quinton J. Tafoya, George Vourakis, Vibhangini S. Wasade, Victoria Watson, Insha Zahoor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f38f3ff4a43cbab22e0c1d9b27db082
https://doi.org/10.1016/b978-0-323-82691-4.09988-x
https://doi.org/10.1016/b978-0-323-82691-4.09988-x
Autor:
Kavita M. Grover, Naganand Sripathi
Publikováno v:
MusclenerveREFERENCES. 62(6)
Myasthenia gravis (MG) is an autoimmune disorder with bimodal age of presentation, occurring in young women of reproductive age and at an older age in men. Occasionally, MG is diagnosed during pregnancy. Management of MG includes symptomatic treatmen
Publikováno v:
Emergencies in Neurology ISBN: 9789811373794
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6040e51b8eb3d8519a24975fe3005f4f
https://doi.org/10.1007/978-981-13-7381-7_5
https://doi.org/10.1007/978-981-13-7381-7_5
Autor:
Naganand Sripathi, Anza B. Memon, Kavita M. Grover, Lonni Schultz, Ximena Arcila-Londono, Bashiruddin K. Ahmad, Sarah Madani
Publikováno v:
Clinical Neurophysiology Practice
Clinical Neurophysiology Practice, Vol 4, Iss, Pp 190-193 (2019)
Clinical Neurophysiology Practice, Vol 4, Iss, Pp 190-193 (2019)
Highlights • CIDP and diabetes can be seen together. • It is difficult to diagnose CIDP in patients with diabetes. • Clinical presentation, nerve conduction studies, and spinal fluid analysis are the best approaches to diagnose CIDP even in pat
Publikováno v:
Musclenerve. 60(3)
Introduction Suprascapular neuropathy (SSN) is rare, with an estimated prevalence of 4.3% in patients with shoulder pain. Methods This retrospective chart review included patients with SSN seen during a 16-year period. Demographics and clinical infor
Autor:
Wendy Peltier, Robert L. Wortmann, Steven K. Baker, Alexandru Barboi, Naganand Sripathi, Mark A. Tarnopolsky, J. Kilpatrick, Alan N. Baer, Heather M. Ochs-Balcom, Beth L. Cobb, Zachary Simmons, John B. Harley, Georgirene D. Vladutiu, Edward J. Fine, Stephen A. Smith, Paul J. Isackson, Jon D. Wilson, Kenneth M. Kaufman, Chang-Xing Ma
Publikováno v:
Muscle & Nerve. 44:531-538
Introduction: Of the nearly 38 million people in the USA who receive statin therapy, 0.1-0.5% experience severe or life-threatening myopathic side effects. Methods: We performed a genome-wide association study (GWAS) in a group of patients with sever
Autor:
Alexandru Barboi, Mark A. Tarnopolsky, Robert L. Wortmann, Naganand Sripathi, Georgirene D. Vladutiu, Paul S. Phillips, Paul J. Isackson, Wendy Peltier, Zachary Simmons
Publikováno v:
Muscle & Nerve. 34:153-162
Lipid-lowering drugs produce myopathic side effects in up to 7% of treated patients, with severe rhabdomyolysis occurring in as many as 0.5%. Underlying metabolic muscle diseases have not been evaluated extensively. In a cross-sectional study of 136